VIRX — Viracta Therapeutics Share News
0.000.00%
Last trade - 00:00Sunesis Pharma: Rises on merger agreement with Viracta Therapeutics
Brief: Sunesis Pharmaceuticals, Viracta Therapeutics Announce Definitive Merger Agreement
Brief: Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results And Recent Highlights
Brief: Sunesis Pharmaceuticals Receives Compliance Letter From Nasdaq
Brief: Sunesis Pharmaceuticals Reports Qtrly Loss Per Share $0.06
Brief: Ayrton Capital Llc Reports 6.65% Passive Stake In Sunesis Pharmaceuticals As Of July 29
Brief: Sunesis Announces Pricing Of $12 Mln Offering Of Common Stock
Brief: Sunesis Announces Proposed Public Offering Of Common Stock
Brief: Sunesis Pharmaceuticals Plans To Review Strategic Alternatives
NASDAQ RESUMED AT 09:31 AM
Sunesis Pharma: Plunges on stopping lead cancer drug development
NASDAQ RESUMED AT 08:00 AM
Brief: Sunesis Pharmaceuticals Announces Clinical Update On Vecabrutinib Program
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:27 AM
Brief: Sunesis Pharmaceuticals - Appointed Dayton Misfeldt, Co's Interim CEO, As Principal Financial Officer
Brief: Sunesis Pharma Says William P. Quinn Provided Notice Of His Resignation As CFO
Brief: Sunesis Pharmaceuticals Says Estimates That Cash, Cash Equivalents, Restricted Cash, Marketable Securities As Of Dec 31, 2019 Was About $34.6 Million
Brief: Sunesis Pharma - Nasdaq Granted Co A Second 180 Day Compliance Period To Demonstrate Compliance
Brief: Sunesis Says Company, Denovo Entered License Agreement For Vosaroxin